Inhibition of glutaminolysis alone and in combination with HDAC inhibitor has anti-myeloma therapeutic effects
{{output}}
Aim: This study aimed to investigate drug candidates and their efficacy in treating refractory multiple myeloma (MM) despite significant therapeutic advances and the introduction of novel agents. Our study focused on how myeloma cells mediate the metabolic pat... ...
